March 4-7 2020 in Szeged, Hungary.
Abstract submission deadline = september 30 2019!
Multimorbidity and the evolving challenge of polypharmacyInnovative medicines - opportunities and challenges
Emerging data capabilities: the opportunities and challenges for DURAntimicrobial Resistance: a One-Health Approach
As well as other familiar drug utilisation topics covering specific therapeutic and patient groups, adherence, intervention and implementation.
Key workshops: appropriate vs inappropriate polypharmacy, policy/practice focus of de-prescribing, DUR in management of new medicines.